A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 641 participants.
Also called NCT01790438
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 641 participants
- Sponsor
- Registry
-
NCT01790438 -
2012-003941-13
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Canada, Czechia, Germany, Hungary, Mexico, Poland, Puerto Rico, South Korea, Spain
- Registry status
- Completed
Technical summary
Registry record NCT01790438. Randomized; no masking; primary purpose treatment. Start 2013-03 (registry gives no type); primary completion 2014-05 (actual). Results posted on 2018-05-03.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes
- Acronym
- IMAGINE 6
- Condition
- Diabetes Mellitus, Type 2
- Intervention (Drug)
- LY2605541
- Intervention (Drug)
- Human Insulin NPH
- Intervention (Drug)
- Oral Antihyperglycemic Medications (OAM)
- Lead sponsor
- Eli Lilly and Company
Record details
- Record id
cardio:ct-nct01790438- Content hash
c266076a5247a511439add90cf03f8c0d5281266ee717005b32d9a0d61fc351c